<DOC>
	<DOCNO>NCT02444858</DOCNO>
	<brief_summary>Phase I-II Clinical Trial-Safety efficacy umbilical-cord-derived mesenchymal stem cell ( UC-MSC ) patient paraquat poison induce lung injury , randomize , single blind , control prospective study .</brief_summary>
	<brief_title>Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy Paraquat Poisoning Induced Lung Injury</brief_title>
	<detailed_description>Phase I-II Clinical Trial-Safety efficacy umbilical-cord-derived mesenchymal stem cell ( UC-MSC ) patient paraquat poison induce lung injury , randomize , single blind , control prospective study . Forty patient select randomized two group : first group 20 patient receive three-time injection UC-MSC remain 20 patient comprise control group . Every patient maintain standard treatment paraquat poisoning , maximum tolerated dosage without side effect . The day last infusion consider day zero . From moment , followup divide 2 d,7 d,14 , 28 2 m. Clinical result analyze completion 2 month followup .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Poisoning</mesh_term>
	<criteria>Age 15 60 ( include 15y ) A history ingestion paraquat , hospitalization within 96 hour paraquat poison No previous organic disease history serious heart , liver , kidney lung , etc ; Patients moderate poisoning ( oral dose 2040mg PQ ion/kg body weight ) Patient legal agent sign informed consent voluntarily Capable good communication researcher follow entire test requirement Refused sign inform consent Elderly highrisk patient Socially mentally disabilities Hepatitis B , hepatitis C , HIV tuberculosis patient Pregnant perinatal woman Severe organ failure patient Patients participate clinical trial drug within 3 month Other circumstance suitable trial ( mixed toxicant poison )</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>paraquat poisoning</keyword>
	<keyword>lung injury</keyword>
	<keyword>stem cell therapy</keyword>
	<keyword>human umbilical cord mesenchymal stem cell</keyword>
	<keyword>phase 1/2 clinical study</keyword>
	<keyword>allogeneic stem cell transplantation</keyword>
</DOC>